The scope and scale of the biotech industry are ever-expanding. Also, the growing integration of cutting-edge technology with biotechnology to accelerate innovation and drug candidate identification is creating new avenues for emerging and innovative biotech companies.
Given the industry’s positive prospects, it could be ideal to invest in quality biotech stocks Royalty Pharma PLC (RPRX), BioMarin Pharmaceutical Inc. (BMRN), and Biogen Inc. (BIIB) with huge upside based on analyst price targets.
